A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes

ConclusionsThis large national study in nsqNSCLC patients confirms thatEGFR exon 20ins is a rare condition (0.6%). The prognosis associated with exon 20ins appears to be in line with that of wild-typeEGFR, but worse than commonEGFR mutations, highlighting the need for advancements for this rare population.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research